Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague-Dawley rats

Reproductive Toxicology

Volumn 31, Issue 1, 2011, Pages 1-9

  Prins, Gail S ^a   Ye, Shu Hua ^a   Birch, Lynn ^a   Ho, Shuk mei ^b   Kannan, Kurunthachalam ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Bisphenol A; BPA; Pharmacokinetics; Prostate; Prostate intraepithelial neoplasia

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ESTROGEN;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DOSIMETRY; ENVIRONMENTAL EXPOSURE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NEWBORN; NONHUMAN; PROSTATE CANCER; RAT; SPRAGUE DAWLEY RAT; TANDEM MASS SPECTROMETRY; TOXICOKINETICS;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; ESTROGENS, NON-STEROIDAL; INJECTIONS, SUBCUTANEOUS; MALE; PHENOLS; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 79551575231     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2010.09.009     Document Type: Article

References (43)

1. Sajiki J., Yonekubo J. Leaching of bisphenol A (BPA) to seawater from polycarbonate plastic and its degradation by reactive oxygen species. Chemosphere 2003, 51:55-62.
2. Kawahata H., Ohta H., Inoue M., Suzuki A. Endocrine disrupter nonylphenol and bisphenol A contamination in Okinawa and Ishigaki Islands, Japan - within coral reefs and adjacent river mouths. Chemosphere 2004, 55:1519-1527.
3. Teuten E., Saquing J., Knappe D., et al. Transport and release of chemicals from plastics to the environment and to wildlife. Philos Trans R Soc Lond B Biol Sci 2009, 364:2027-2045.
4. Nam S.H., Seo Y.M., Kim M.G. Bisphenol A migration from polycarbonate baby bottle with repeated use. Chemosphere 2010, 79:949-952.
5. Calafat A.M., Kuklenyik Z., Reidy J.A., Caudill S.P., Ekong J., Needham L.L. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Prospect 2005, 113:391-395.
6. Calafat A.M., Ye X., Wong L.Y., Reidy J.A., Needham L.L. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Prospect 2008, 116:39-44.
7. Kuroda N., Kinoshita Y., Sun Y., et al. Measurement of bisphenol A levels in human blood serum and ascitic fluid by HPLC using a fluorescent labeling reagent. J Pharm Biol Anal 2003, 30:1743-1749.
8. Lee Y.J., Ryu H.Y., Kim H.K., et al. Maternal and fetal exposure to bisphenol A in Korea. Reprod Toxicol 2008, 25:413-419.
9. Calafat A.M., Weuve J., Ye X., et al. Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect 2009, 117:639-644.
10. Eddington A.N., Ritter L. Predicting plasma concentrations of bisphenol A in children younger than 2 years of age after typical feeding schedules, using a physiologically based toxicokinetic model. Environ Health Perspect 2009, 117:645-652.
11. Vandenberg L.N., Hauser R., Marcus M., Olea N., Welshons W.V. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007, 24:139-177.
12. Krishnan A.V., Stathis P., Permuth S.F., Tokes L., Feldman D. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 1993, 132:2279-2286.
13. Quesada I., Fuentes E., Viso-Leon M.C., Ripoll C., Nadal A. Low doses of the endocrine disruptor bisphenol-A and the native hormone 17β-estradiol rapidly activate the transcription factor CREB. FASEB J 2002, 16:1671-1673.
14. Zsarnovszky A., Le H.H., Wang H.S., Belcher S.M. Ontogeny of rapid estrogen-mediated extracellular signal-regulated kinase signaling in the rat cerebellar cortex: potent nongenomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A. Endocrinology 2005, 146:5296-5388.
15. Wetherill Y.B., Akingbemi B.T., Kanno J., et al. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 2007, 24:178-198.
16. Shelby M. National toxicology program - CERHR monograph on the potential human reproductive and developmental effects of bisphenol A. NIH publication no. 08-5994; 2008.
17. Prins G.S. Developmental estrogenization of the prostate gland. Prostate: basic and clinical aspects 1997, 247-265. CRC Press, Boca Raton, [chapter 10]. R.K. Naz (Ed.).
18. Prins G.S., Huang L., Birch L., Pu Y. The role of estrogens in normal and abnormal development of the prostate gland. Ann NY Acad Sci 2006, 1089:1-13.
19. Prins G.S., Birch L., Tang W.Y., Ho S.M. Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod Toxicol 2007, 23:374-382.
20. Ho S.M., Tang W.Y., Belmonte J., Prins G.S. Developmental exposure estradiol and bisphenol A (BPA) increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant (PDE4D4) in the rat prostate. Cancer Res 2006, 66:5624-5632.
21. Kaufman J.M., Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005, 26:833-876.
22. Dekant W., Völkel W. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol Appl Pharmacol 2008, 228:118-134.
23. Yokota H., Iwano H., Endo M., et al. Glucuronidation of the environmental oestrogen bisphenol A by an isoform of UDP-glucuronosyltransferase, UGT2B1, in the rat liver. Biochem J 1999, 340:405-409.
24. Matsumoto J., Yokota H., Yuasa A. Developmental increases in rat hepatic microsomal UDP-glucuronosyltransferase activities toward xenoestrogens and decreases during pregnancy. Environ Health Perspect 2002, 110:193-196.
25. EFSA and Panel on Food Additives F, Processing Aids and Materials in Contact with Foods (AFC) Toxicokinetics of bisphenol a - scientific opinion of the panel on food additives, flavourings, processing aids and materials in contact with food (AFC). EFSA J 2008, 6.
26. Padmanabhan V., Siefert K., Ransom S., et al. Maternal bisphenol-A levels at delivery: a looming problem?. J Perinatol 2008, 28:258-263.
27. Bosland M.C., Ford H., Horton L. Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17β or diethylstilbestrol. Carcinogenesis 1995, 16:1311-1317.
28. Shappell S., Thomas D., Roberts R., et al. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Biology Committee. Cancer Res 2004, 64:2270-2305.
29. Domoradzki J.Y., Thornton C.M., Pottenger L.H., et al. Age and dose dependency of the pharmacokinetics and metabolism of bisphenol A in neonatal Sprague-Dawley rats following oral administration. Toxicol Sci 2004, 77:230-242.
30. Doerge D., Twaddle N.C., Vanlaningham M., Fischer J.W. Pharmacokinetics of bisphenol-A in neonatal and adult Sprague-Dawley rats. Toxicol Appl Pharmacol 2010, 246. 10.1016/j.taap.2010.06.008.
31. Schonfelder G, Wittfoht W., Hopp H., Talsness C.E., Paul M., Chahoud I. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Prospect 2002, 110:A703-A707.
32. Calafat A.M., Ye X., Silva M.J., Kuklenyik Z., Needham L.L. Human exposure assessment to environmental chemicals using biomonitoring. Int J Androl 2006, 29:166-171.
33. Ye X., Tao L.J., Needham L.L., Calafat A.M. Automated on-line column switching HPLC MS/MS method for measuring environmental phenols and parabens in serum. Talanta 2008, 76:865-871.
34. Matsumoto J., Yokota H., Yuasa A. Developmental increases in rat hepatic microsomal UDP-glucuronyltransferase activities toward xenoestrogens and decreases during pregnancy. Environ Health Perspect 2002, 110:193-196.
35. Pottenger L.H., Domoradzki J.Y., Markham D.A., Hansen S.C., Cagen S.Z., Waechter J.M.J. The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol Sci 2000, 54:3-18.
36. Watanabe E., Sudo R., Takahashi M., Hayashi M. Evaluation of absorbability of poorly water soluble drugs: validity of the use of additives. Biol Pharm Bull 2000, 23:838-843.
37. Hu X.L., Peng J.F., Liu J.F., Jiang G.B., Jönsson J.A. Evaluating the impacts of some environmentally relevant factors on the availability of bisphenol A with negligible-depletion SPME. Chemosphere 2006, 65:1935-1941.
38. Latendresse J.R., Bucci T.J., Olson G., et al. Genistein and ethinyl estradiol dietary exposure in multigenerational and chronic studies induce similar proliferative lesions in mammary gland of male Sprague-Dawley rats. Reprod Toxicol 2009, 28:342-353.
39. Spearow JL. Reviewer's appendix to the EPA white paper on species/stock/strain in endocrine disruptor assays. Contract # 68-W-01-023, Assignment #4-5, Task #16. White paper| Endocrine Disruptor Screening Program | US EPA; 2007. http://www.epa.gov/endo/pubs/program/whitepaper.htm.
40. Taylor J.A., Welshins W.V., vom Saal F.S. No effect of route of exposure (oral; subcutaneous injection) on plasma bisphenol A throughout 24h after administration in neonatal female mice. Reprod Toxicol 2008, 25:169-176.
41. Yan H., Takamoto M., Sugane K. Exposure to bisphenol A prenatally or in adulthood promotes T(H)2 cytokine production associated with reduction of CD4CD25 regulatory T cells. Environ Health Perspect 2008, 116:514-519.
42. DeMarzo A.M., Marchi V.L., Epstein J.I., Nelson W.G. Proliferative inflammatory atrophy of the prostate implications for prostatic carcinogenesis. Am J Pathol 1999, 155:1985-1992.
43. Bernoulli J, Yatkin E, Laakso A, et al. Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat. 2008;68:7.